Postdoc Plight

Thank you for the update on the status and plight of postdocs.1 I personally spent 11 years on the postdoc/research associate circuit, and found that expectations for performance relative to the salary, benefits, and opportunities for advancement were totally unrealistic. I became less competitive in the grant "game" each year that passed, not because of my proposals, but because I was seen as "not productive." Catch-22! Many of my colleagues dropped out and pursued non-life science careers in

Written byBarbara Zimmerman
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Thank you for the update on the status and plight of postdocs.1 I personally spent 11 years on the postdoc/research associate circuit, and found that expectations for performance relative to the salary, benefits, and opportunities for advancement were totally unrealistic. I became less competitive in the grant "game" each year that passed, not because of my proposals, but because I was seen as "not productive." Catch-22! Many of my colleagues dropped out and pursued non-life science careers in the information technology industries.

Four years ago, I decided that there was more to life than the narrow confines of my lab. I chose to translate my knowledge to the layperson, and I am developing a freelance business as a biomedical communicator and consultant. At the most recent national meeting of the American Medical Writers Association, nearly half of the attendees were former life scientists or clinicians. We have not abandoned the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies